SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-064136
Filing Date
2013-12-20
Accepted
2013-12-20 19:10:22
Documents
1
Period of Report
2013-12-19

Document Format Files

Seq Description Document Type Size
1 F4 MALLEY 12-19-13 AWARD rrd398167.html 4  
1 F4 MALLEY 12-19-13 AWARD rrd398167.xml 4 3965
  Complete submission text file 0001181431-13-064136.txt   5430
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Issuer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 295 CLAYTON DENVER CO 80206
Business Address
Malley Thomas (Reporting) CIK: 0001403322 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35703 | Film No.: 131292886